68 related articles for article (PubMed ID: 23466456)
1. BMP4 reverses multidrug resistance through modulation of BCL-2 and GDNF in glioblastoma.
Liu B; Chen Q; Tian D; Wu L; Dong H; Wang J; Ji B; Zhu X; Cai Q; Wang L; Zhang S
Brain Res; 2013 Apr; 1507():115-24. PubMed ID: 23466456
[TBL] [Abstract][Full Text] [Related]
2. GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis.
Ku MC; Wolf SA; Respondek D; Matyash V; Pohlmann A; Waiczies S; Waiczies H; Niendorf T; Synowitz M; Glass R; Kettenmann H
Acta Neuropathol; 2013 Apr; 125(4):609-20. PubMed ID: 23344256
[TBL] [Abstract][Full Text] [Related]
3. Glial Cell Line-Derived Neurotrophic Factor (GDNF) Promotes Angiogenesis through the Demethylation of the Fibromodulin (FMOD) Promoter in Glioblastoma.
Chen M; Ba H; Lu C; Dai J; Sun J
Med Sci Monit; 2018 Sep; 24():6137-6143. PubMed ID: 30176167
[TBL] [Abstract][Full Text] [Related]
4. Controlling tumor invasion: bevacizumab and BMP4 for glioblastoma.
Rahman M; Azari H; Deleyrolle L; Millette S; Zeng H; Reynolds BA
Future Oncol; 2013 Sep; 9(9):1389-96. PubMed ID: 23980685
[TBL] [Abstract][Full Text] [Related]
5. Effect of bone morphogenetic protein 4 in the human brain glioma cell line U251.
Liu B; Tian D; Yi W; Wu L; Cai Q; Dong H; Shen H; Ji B; Wang L; Zhang S; Ruan D; Chen Q
Cell Biochem Biophys; 2010 Nov; 58(2):91-6. PubMed ID: 20730570
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma cells deficient in DNA-dependent protein kinase are resistant to cell death.
Chen GG; Sin FL; Leung BC; Ng HK; Poon WS
J Cell Physiol; 2005 Apr; 203(1):127-32. PubMed ID: 15493013
[TBL] [Abstract][Full Text] [Related]
7. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells.
Wang G; Rong J; Zhou Z; Duo J
Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809
[TBL] [Abstract][Full Text] [Related]
8. BMP4 inhibits glioblastoma invasion by promoting E-cadherin and claudin expression.
Zhao X; Sun Q; Dou C; Chen Q; Liu B
Front Biosci (Landmark Ed); 2019 Mar; 24(6):1060-1070. PubMed ID: 30844730
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines.
Avramis IA; Christodoulopoulos G; Suzuki A; Laug WE; Gonzalez-Gomez I; McNamara G; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2002 Dec; 50(6):479-89. PubMed ID: 12451475
[TBL] [Abstract][Full Text] [Related]
10. Growth-Inhibitory Activity of Bone Morphogenetic Protein 4 in Human Glioblastoma Cell Lines Is Heterogeneous and Dependent on Reduced SOX2 Expression.
Dalmo E; Johansson P; Niklasson M; Gustavsson I; Nelander S; Westermark B
Mol Cancer Res; 2020 Jul; 18(7):981-991. PubMed ID: 32234828
[TBL] [Abstract][Full Text] [Related]
11. Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme.
Chu SH; Ma YB; Feng DF; Li ZQ; Jiang PC
Mol Med Rep; 2013 Jan; 7(1):139-43. PubMed ID: 23076250
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
[TBL] [Abstract][Full Text] [Related]
13. Glial cell line-derived neurotrophic factor promotes invasive behaviour in testicular seminoma cells.
Ferranti F; Muciaccia B; Ricci G; Dovere L; Canipari R; Magliocca F; Stefanini M; Catizone A; Vicini E
Int J Androl; 2012 Oct; 35(5):758-68. PubMed ID: 22519471
[TBL] [Abstract][Full Text] [Related]
14. LRIG1 improves chemosensitivity through inhibition of BCL-2 and MnSOD in glioblastoma.
Ding J; Liu B; He Y; Yuan X; Tian D; Ji B; Wang L; Wu L; Dong H; Wang J; Zhu X; Cai Q; Zhang S; Chen Q
Cell Biochem Biophys; 2015 Jan; 71(1):27-33. PubMed ID: 25449296
[TBL] [Abstract][Full Text] [Related]
15. The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines.
Podolski-Renić A; Andelković T; Banković J; Tanić N; Ruždijić S; Pešić M
Biomed Pharmacother; 2011 Aug; 65(5):345-53. PubMed ID: 21775090
[TBL] [Abstract][Full Text] [Related]
16. Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease.
Lei Z; Jiang Y; Li T; Zhu J; Zeng S
J Neuropathol Exp Neurol; 2011 Sep; 70(9):736-47. PubMed ID: 21865882
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
[TBL] [Abstract][Full Text] [Related]
18. Glial cell line-derived neurotrophic factor influences proliferation of osteoblastic cells.
Gale Z; Cooper PR; Scheven BA
Cytokine; 2012 Feb; 57(2):276-81. PubMed ID: 22142702
[TBL] [Abstract][Full Text] [Related]
19. Expression of glial cell line-derived neurotrophic factor family members and their receptors in pancreatic cancers.
Ito Y; Okada Y; Sato M; Sawai H; Funahashi H; Murase T; Hayakawa T; Manabe T
Surgery; 2005 Oct; 138(4):788-94. PubMed ID: 16269310
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal gene delivery of glial cell line-derived neurotrophic factor ameliorated paraplegia in rats after spinal ischemia.
Chou AK; Yang LC; Wu PC; Wong WT; Liu GS; Chen JT; Howng SL; Tai MH
Brain Res Mol Brain Res; 2005 Feb; 133(2):198-207. PubMed ID: 15710236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
